Europe Allergy Diagnostics And Treatment Market was valued at USD 3.9 Billion in 2022 and is projected to reach USD 7.8 Billion by 2030, growing at a CAGR of 8.9% from 2024 to 2030.
Europe's Allergy Diagnostics and Treatment Market: Industry Requirements and Growth Dynamics
Allergies have become a significant health concern across Europe, affecting a substantial portion of the population. The region's allergy diagnostics and therapeutics market was valued at approximately USD 10.72 billion in 2023 and is projected to reach USD 15.74 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period. This growth underscores the escalating demand for effective diagnostic tools and treatments.
Key Market Drivers
Rising Allergy Prevalence: Over 20% of the global population suffers from allergies, with Europe witnessing a similar trend. Factors such as urbanization, environmental changes, and lifestyle modifications contribute to this increase.
Advancements in Diagnostics: Innovations in diagnostic technologies, including molecular diagnostics and component-resolved diagnostics, have enhanced the accuracy and efficiency of allergy detection, leading to early interventions.
Therapeutic Developments: The introduction of novel biologics, such as Xolair and Dupixent, has revolutionized allergy treatment, offering hope to patients with severe allergic conditions. These biologics target specific pathways involved in allergic reactions, providing more effective management options.
Industry Requirements and Opportunities
Standardization of Diagnostic Protocols: There's a pressing need for harmonized diagnostic guidelines across Europe to ensure consistent and accurate allergy diagnoses. This standardization will facilitate better patient management and data comparability.
Investment in Research and Development (R&D): Continuous R&D is crucial for understanding emerging allergens and developing corresponding diagnostics and therapeutics. Companies investing in R&D are better positioned to address unmet clinical needs and capture market share.
Regulatory Compliance: Adherence to stringent regulatory standards is essential for market approval and patient safety. Companies must navigate the complex regulatory landscape to bring innovative products to market.
Patient-Centric Approaches: Developing personalized treatment plans based on individual allergen sensitivities can enhance therapeutic outcomes. Emphasizing patient education and engagement is also vital for effective allergy management.
Market Segmentation and Trends
By Allergen Type:
Inhaled Allergens: This segment dominated the market in 2023, accounting for 49.52% of the revenue. Common inhaled allergens include pollen, dust mites, and animal dander.
Food Allergens: With the increasing prevalence of food allergies, this segment is witnessing significant growth. Innovations in oral immunotherapy and allergen-specific immunotherapy are gaining traction.
Drug Allergens: Adverse reactions to medications necessitate accurate diagnostics to prevent severe outcomes. This segment emphasizes the development of tests for antibiotic and analgesic allergies.
Other Allergens: This category, encompassing insect stings and latex allergies, is projected to register the fastest growth during the forecast period.
By Country:
United Kingdom (UK): Expected to register the highest CAGR from 2024 to 2030, driven by robust healthcare infrastructure and increased awareness.
Germany and France: These countries continue to be significant contributors to the market, owing to advanced research facilities and a high prevalence of allergies.
Challenges and Considerations
Underdiagnosis: Despite the high prevalence, many allergic conditions remain undiagnosed due to lack of awareness or access to diagnostic facilities.
Cost Implications: Advanced diagnostics and biologic treatments can be expensive, posing affordability challenges for patients and healthcare systems.
Variability in Clinical Practices: Differences in allergy management protocols across European countries can lead to inconsistent patient outcomes.
Conclusion
The European allergy diagnostics and treatment market is poised for substantial growth, driven by increasing allergy prevalence and advancements in medical technologies. However, addressing industry requirements such as standardization, R&D investment, and regulatory compliance is crucial. By focusing on these areas, stakeholders can enhance patient outcomes and capitalize on emerging market opportunities.
Get an In-Depth Research Analysis of the Europe Allergy Diagnostics And Treatment Market Size And Forecast [2025-2032]
Alcon Laboratories
Inc
BioMerieux
Inc Danaher Corporation
Hitachi Chemical Diagnostics
Inc HOB Biotech Group Co.
Ltd.
Hycor Biomedical
Inc
Incln Diagnostics
Inc
Omega Diagnostics Plc.
Siemens Healthcare Diagnostic
Inc
Stallergenes Greer
Inc
Thermo Fisher Scientific
Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Allergy Diagnostics And Treatment Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Allergy Diagnostics And Treatment Market
Food Allergy
Drug Allergy
Inhalant Allergy
Contact Allergy
Others
Skin Prick Test
Blood Test
Patch Test
Elimination Diet
Challenge Test
Antihistamines
Corticosteroids
Immunotherapy
Leukotriene Receptor Antagonists
Decongestants
Hospitals
Diagnostic Laboratories
Home Care Settings
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Allergy Diagnostics And Treatment Market Research Analysis
1. Introduction of the Europe Allergy Diagnostics And Treatment Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Allergy Diagnostics And Treatment Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Allergy Diagnostics And Treatment Market, By Type
6. Europe Allergy Diagnostics And Treatment Market, By Application
7. Europe Allergy Diagnostics And Treatment Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Allergy Diagnostics And Treatment Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/